BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12101253)

  • 1. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
    Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
    Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
    Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
    Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
    Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II enhanceosome: how is the class II transactivator recruited to DNA-bound activators?
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman L; Peterlin BM
    Int Immunol; 2003 Apr; 15(4):467-75. PubMed ID: 12663676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
    Zika E; Greer SF; Zhu XS; Ting JP
    Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations and interactions between bare lymphocyte syndrome factors.
    DeSandro AM; Nagarajan UM; Boss JM
    Mol Cell Biol; 2000 Sep; 20(17):6587-99. PubMed ID: 10938133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assembly of functional regulatory complexes on MHC class II promoters in vivo.
    Fontes JD; Jabrane-Ferrat N; Peterlin BM
    J Mol Biol; 1997 Jul; 270(3):336-45. PubMed ID: 9237901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
    Scholl T; Mahanta SK; Strominger JL
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6330-4. PubMed ID: 9177217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the defect in IFN-gamma induction of MHC class II genes in G1B cells: identification of a novel and functionally critical leucine-rich motif (62-LYLYLQL-68) in the regulatory factor X 5 transcription factor.
    Brickey WJ; Wright KL; Zhu XS; Ting JP
    J Immunol; 1999 Dec; 163(12):6622-30. PubMed ID: 10586057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex.
    Nekrep N; Jabrane-Ferrat N; Peterlin BM
    Mol Cell Biol; 2000 Jun; 20(12):4455-61. PubMed ID: 10825209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions.
    Jabrane-Ferrat N; Fontes JD; Boss JM; Peterlin BM
    Mol Cell Biol; 1996 Sep; 16(9):4683-90. PubMed ID: 8756625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hierarchy of nuclear localization signals governs the import of the regulatory factor X complex subunits and MHC class II expression.
    Nagarajan UM; Long AB; Harreman MT; Corbett AH; Boss JM
    J Immunol; 2004 Jul; 173(1):410-9. PubMed ID: 15210800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).
    Steimle V; Durand B; Barras E; Zufferey M; Hadam MR; Mach B; Reith W
    Genes Dev; 1995 May; 9(9):1021-32. PubMed ID: 7744245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the RFX complex and the RFX5(L66A) mutant: implications for the regulation of MHC class II gene expression.
    Garvie CW; Stagno JR; Reid S; Singh A; Harrington E; Boss JM
    Biochemistry; 2007 Feb; 46(6):1597-611. PubMed ID: 17279624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RFX family interacts at the collagen (COL1A2) start site and represses transcription.
    Sengupta PK; Fargo J; Smith BD
    J Biol Chem; 2002 Jul; 277(28):24926-37. PubMed ID: 11986307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells.
    Nagarajan UM; Peijnenburg A; Gobin SJ; Boss JM; van den elsen PJ
    J Immunol; 2000 Apr; 164(7):3666-74. PubMed ID: 10725724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.